Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

168.23 -0.66 (-0.39%)
Official Closing Price Updated: 7:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
54 55 Next >
2 Blue Chips Under Pressure
Plus, Motley Fool personal finance expert Robert Brokamp answers your questions. 
Via The Motley Fool
3 Beaten-Down Blue Chip Stocks to Buy Right Now
These solid stocks are down but definitely not out. 
Via The Motley Fool
3 Low-Risk Dividend Stocks to Buy in 2023
These stocks should allow you to sleep peacefully no matter what happens with the stock market this year. 
Via The Motley Fool
2 of the Best Dividend Stocks to Own in 2023
You can count on them for passive income and growth over time. 
Via The Motley Fool
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
Stocks reacted well to uneven earnings and economic reports. 
Via Investor's Business Daily
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
JNJ earnings call for the period ending December 31, 2022. 
Via The Motley Fool
The 3 Best Biotech Stocks Under $1 to Buy for January
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich. 
Via InvestorPlace
3 Warren Buffett Stocks That Could Make You Richer in 2023
These Buffett stocks are poised for a big 2023. 
Via The Motley Fool
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
A disappointing fourth-quarter performance has some investors worried about the giant healthcare conglomerate's outlook. 
Via The Motley Fool
3 Perfect Stocks for Retirees to Buy Hand Over Fist During the Nasdaq Bear Market
These highly profitable, industry-leading companies are ideal for retired investors. 
Via The Motley Fool
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
3 Must-Own Dividend Stocks
All 3 of these dividend stocks pay safe, reliable, and growing dividends 
Via The Motley Fool
Intraday Technical Analysis Of Johnson & Johnson
Looking at the JNJ’s chart, we can see that it is currently traded at around $168.40. 
Via Talk Markets
Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday
Keybanc raised the price target for Reliance Steel & Aluminum Co. (NYSE: RS) from $225 to $235. Keybanc analyst Philip Gibbs maintained an Overweight rating. Reliance Steel shares fell 0.2% to close at... 
Via Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
U.S. stocks look set to start Wednesday’s session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. Cues From Tuesday’s Trading: 
Via Benzinga
3 Reasons Why Johnson & Johnson Stock Could Rebound After a Bad Start in 2023
J&J's future prospects look brighter than its year-to-date stock performance might imply. 
Via The Motley Fool
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate. 
Via MarketBeat
Topics Workforce
Exposures Layoff Product Safety
Why Johnson & Johnson Stock Was Stagnant Today
Investors were on the fence about the company's performance in the final months of last year. 
Via The Motley Fool
The Earnings Shall Continue! Today's Key Updates For You
Another day, another round of fresh new earnings and plays to take in the news-fueled volatility. 
Via Talk Markets
Most Active Equity Options For Midday - Tuesday, Jan. 24
Here are the most active equity options for midday. 
Via Talk Markets
Why Are Stocks Down Today?
Among the prominent stocks down in early trading are Johnson & Johnson, 3M, and Verizon, which reported quarterly results today. 
Via InvestorPlace
Trump Beefs Up Defamation War Against New York Prosecutor, Apple Weighs Content Deals With Disney, Likely Lawsuit On Google For Influencing Online Ad Market: Today's Top Stories
Benzinga 
Via Benzinga
Johnson & Johnson Beats Profit Views, But Light Sales, Outlook Chip At Shares
Guidance for 2023 came in mixed following disappointing fourth-quarter sales. 
Via Investor's Business Daily
Johnson & Johnson Q4 Earnings Top Estimates
Johnson & Johnson came out with quarterly earnings of $2.35 per share 
Via Talk Markets
Johnson & Johnson Reports Mixed Q4 Earnings, Issues FY23 Guidance Edging Higher Than Street Consensus
 
Via Benzinga
US Stocks Look Set For Lower Start On Tuesday Ahead Of Microsoft's Earnings: Analysts Caution Of More Near-Term Volatility
The index futures signal a nervous start on Wall Street as the breathtaking rally of the past two sessions and the imminent tech earnings force traders to go on the defensive. Cues From Monday’s... 
Via Benzinga
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
From Johnson & Johnson
Via Business Wire
3 Outstanding Dividend Stocks You Can Buy Now and Hold Forever
For years, these businesses have impressed investors with their ability to raise quarterly dividend payouts. 
Via The Motley Fool
Earnings Scheduled For January 24, 2023
Companies Reporting Before The Bell • GATX (NYSE:GATX) is expected to report quarterly earnings at $1.44 per share on revenue of $327.63 million. 
Via Benzinga
Microsoft, Verizon Communications And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading mostly flat this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
54 55 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.